Sied Kebir

Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma

Martin Glas, Elke Hattingen, Rolf Fimmers, 2016, Oncotarget.

Hybrid 11C-MET PET/MRI Combined With “Machine Learning” in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016

Martin Glas, Ulrich Sure, Christoph Mönninghoff, 2019, Clinical nuclear medicine.

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Martin Glas, Michael Sabel, Jörg-Christian Tonn, 2019, The Lancet.

Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET

Gereon R. Fink, Karl-Josef Langen, Martin Kocher, 2015, European Journal of Nuclear Medicine and Molecular Imaging.